|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/145 | (2006.01) |
| C12Q 1/70 | (2006.01) |
| (11) | Patento numeris | 2578229 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12193096.0 |
| Europos patento paraiškos padavimo data | 2005-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-04-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-07-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 04255471 | 2004-09-09 | EP |
| (72) |
Gregersen, Jens Peter, DE
|
| (73) |
Novartis Vaccines and Diagnostics GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | Decreasing potential iatrogenic risks associated with vaccine antigens |
| Decreasing potential iatrogenic risks associated with vaccine antigens |